Feasibility and outcomes of using DIALOG+ in primary care to improve quality of life and mental distress of patients with long-term physical conditions: an exploratory non-controlled study in Bosnia and Herzegovina, Colombia and Uganda.
DIALOG+
Global mental health
LMICs
Primary care
Psychosocial interventions
Quality of life
Resource-oriented approach
Solution-focused
Journal
BMC primary care
ISSN: 2731-4553
Titre abrégé: BMC Prim Care
Pays: England
ID NLM: 9918300889006676
Informations de publication
Date de publication:
16 Nov 2023
16 Nov 2023
Historique:
received:
17
02
2023
accepted:
30
10
2023
medline:
27
11
2023
pubmed:
16
11
2023
entrez:
16
11
2023
Statut:
epublish
Résumé
The management of long-term physical conditions is a challenge worldwide, absorbing a majority resources despite the importance of acute care. The management of these conditions is done largely in primary care and so interventions to improve primary care could have an enormous impact. However, very little data exist on how to do this. Mental distress is frequently comorbid with long term physical conditions, and can impact on health behaviour and adherence, leading to poorer outcomes. DIALOG+ is a low-cost, patient-centred and solution-focused intervention, which is used in routine patient-clinician meetings and has been shown to improve outcomes in mental health care. The question arises as to whether it could also be used in primary care to improve the quality of life and mental health of patients with long-term physical conditions. This is particularly important for low- and middle-income countries with limited health care resources. An exploratory non-controlled multi-site trial was conducted in Bosnia and Herzegovina, Colombia, and Uganda. Feasibility was determined by recruitment, retention, and session completion. Patient outcomes (quality of life, anxiety and depression symptoms, objective social situation) were assessed at baseline and after three approximately monthly DIALOG+ sessions. A total of 117 patients were enrolled in the study, 25 in Bosnia and Herzegovina, 32 in Colombia, and 60 in Uganda. In each country, more than 75% of anticipated participants were recruited, with retention rates over 90% and completion of the intervention exceeding 92%. Patients had significantly higher quality of life and fewer anxiety and depression symptoms at post-intervention follow-up, with moderate to large effect sizes. There were no significant improvements in objective social situation. The findings from this exploratory trial suggest that DIALOG+ is feasible in primary care settings for patients with long-term physical conditions and may substantially improve patient outcomes. Future research may test implementation and effectiveness of DIALOG+ in randomized controlled trials in wider primary care settings in low- and middle-income countries. All studies were registered prospectively within the ISRCTN Registry. ISRCTN17003451, 02/12/2020 (Bosnia and Herzegovina), ISRCTN14018729, 01/12/2020 (Colombia) and ISRCTN50335796, 02/12/2020 (Uganda).
Identifiants
pubmed: 37968592
doi: 10.1186/s12875-023-02197-0
pii: 10.1186/s12875-023-02197-0
pmc: PMC10652546
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
241Subventions
Organisme : National Institute for Health and Care Research
ID : 16/137/97
Organisme : National Institute for Health and Care Research
ID : 16/137/97
Organisme : National Institute for Health and Care Research
ID : 16/137/97
Organisme : National Institute for Health and Care Research
ID : 16/137/97
Organisme : National Institute for Health and Care Research
ID : 16/137/97
Organisme : National Institute for Health and Care Research
ID : 16/137/97
Organisme : National Institute for Health and Care Research
ID : 16/137/97
Organisme : National Institute for Health and Care Research
ID : 16/137/97
Organisme : National Institute for Health and Care Research
ID : 16/137/97
Organisme : National Institute for Health and Care Research
ID : 16/137/97
Organisme : National Institute for Health and Care Research
ID : 16/137/97
Organisme : National Institute for Health and Care Research
ID : 16/137/97
Organisme : National Institute for Health and Care Research
ID : 16/137/97
Informations de copyright
© 2023. The Author(s).
Références
N Engl J Med. 1984 Aug 23;311(8):506-11
pubmed: 6749208
Pilot Feasibility Stud. 2021 Sep 30;7(1):180
pubmed: 34593055
BMJ. 2019 Sep 23;366:l4516
pubmed: 31548204
Int J Public Health. 2009 Jun;54 Suppl 1:1-3
pubmed: 19396582
BMC Public Health. 2005 Jul 19;5:77
pubmed: 16029495
Health Qual Life Outcomes. 2010 Jan 20;8:8
pubmed: 20089179
Health Qual Life Outcomes. 2005 Sep 01;3:51
pubmed: 16137329
Lancet. 2012 Jul 7;380(9836):37-43
pubmed: 22579043
Arch Gen Psychiatry. 2007 Aug;64(8):966-74
pubmed: 17679641
AIDS Care. 2015;27(1):59-62
pubmed: 25303372
Afr J Psychiatry (Johannesbg). 2012 Nov;15(6):402-5
pubmed: 23160613
J Gen Intern Med. 1995 Feb;10(2):59-66
pubmed: 7730940
PLoS One. 2016 Jun 16;11(6):e0156939
pubmed: 27310297
Glob Health Action. 2014 May 15;7:23431
pubmed: 24848654
Health Policy Plan. 2019 Nov 1;34(9):706-719
pubmed: 31544948
Psychiatry Res Commun. 2023 Mar;3(1):None
pubmed: 36911535
PLoS Med. 2013;10(5):e1001443
pubmed: 23690753
Psychiatry Res. 2022 Jan;307:114335
pubmed: 34920396
Psychiatr Serv. 2004 Dec;55(12):1408-13
pubmed: 15572569
Rev Colomb Psiquiatr (Engl Ed). 2021 Jan-Mar;50(1):11-21
pubmed: 33648690
Int J Ment Health Syst. 2011 Apr 15;5:8
pubmed: 21496242
Br J Psychiatry. 2014;204:256-61
pubmed: 24692752
AIDS Care. 2010 Feb;22(2):159-65
pubmed: 20390494
Ann Fam Med. 2004 Nov-Dec;2(6):555-62
pubmed: 15576541
BMC Psychiatry. 2019 Apr 3;19(1):107
pubmed: 30943947
PLoS One. 2016 Feb 09;11(2):e0148415
pubmed: 26859388
Lancet. 2007 Sep 8;370(9590):851-8
pubmed: 17826170
Int J Soc Psychiatry. 1999 Spring;45(1):7-12
pubmed: 10443245
Iran J Psychiatry. 2023 Jan;18(1):1-10
pubmed: 37159641
Soc Psychiatry Psychiatr Epidemiol. 2012 Feb;47(2):175-84
pubmed: 21184214
Health Qual Life Outcomes. 2004 Sep 20;2:51
pubmed: 15380021
Ann Fam Med. 2015 Nov;13(6):573-82
pubmed: 26553897
J Psychiatr Res. 2011 May;45(5):626-9
pubmed: 21035130
Acta Psychiatr Scand. 2008 Jul;118(1):57-63
pubmed: 18582348
Psychol Med. 2020 Jun;50(8):1368-1380
pubmed: 31298180
Lancet. 2007 Sep 8;370(9590):859-77
pubmed: 17804063
Med Care. 2008 Mar;46(3):266-74
pubmed: 18388841
Glob Ment Health (Camb). 2016 Jun 20;3:e20
pubmed: 28596888
JAMA. 2016 Jun 28;315(24):2703-11
pubmed: 27367877
BMJ. 2012 Sep 03;345:e5205
pubmed: 22945950
Lancet Healthy Longev. 2021 Nov;2(11):e712-e723
pubmed: 36098028
BMC Psychiatry. 2019 Jun 14;19(1):181
pubmed: 31200671
Int J Obes (Lond). 2013 Aug;37 Suppl 1:S25-30
pubmed: 23921778
Health Policy Plan. 2017 Jun 1;32(5):699-709
pubmed: 28369396
Psychiatry Investig. 2019 Apr;16(4):300-305
pubmed: 31042692
BMC Med. 2016 Jun 22;14(1):88
pubmed: 27328975
J Prim Care Community Health. 2013 Oct;4(4):294-306
pubmed: 23799670
Psychiatry Res Commun. 2021 Dec;1(2):None
pubmed: 35028649
J Gen Intern Med. 2001 Sep;16(9):606-13
pubmed: 11556941
Afr Health Sci. 2021 Mar;21(1):427-436
pubmed: 34394325
Respir Med. 2007 Nov;101(11):2233-9
pubmed: 17804213